Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )

Published by: Kalorama Information

Published: Jul. 1, 2008 - 125 Pages

Table of Contents

• Overview
  
• Scope and Methodology
  
• Size and Growth of the Market
  
• Key Issues and Trends Affecting the Market
  
• Leading Competitors

• Overview
  
• Intellectual Property Rights and Compulsory Licensing
  
• Biosimilar Production
  
• Ethical Issues Regarding DTC Advertising in Developing Regions
  
• World Health
  
  
  • Tobacco Use
    
  • Obesity
  
  
• World Economic Trends
  
• Purchasing Power Trends

• Overview and Summary
  
• Regulatory Environment
  
• Economic Development
  
• Healthcare Trends in India
  
  
  • Healthcare Professionals
  
  
• Demographics
  
  
  • Birth Rates
    
  • Life Expectancy
    
  • Mortality
    
  • Leading Causes of Death
  
  
• Key Product Segments and Market Indicators
  
  
  • Cardiovascular Drugs
    
  • Gastrointestinal Drugs
    
  • Infection Control Drugs
    
  • Neurotherapuetics and Central Nervous System Drugs
    
  • Oncology Drugs
    
  • Respiratory Drugs
    
  • Other Drugs
  
  
• Market Analysis
  
  
  • Product Segment Market Analysis
    
  • Competitive Outlook and Distribution

• Overview and Summary
  
  
  • Regulatory Environment
    
  • Economic Development
    
  • Healthcare Trends in China
    
  • Healthcare Professionals
  
  
• Demographics
  
  
  • Birth Rates
    
  • Life Expectancy
    
  • Mortality
    
  • Leading Causes of Death
  
  
• Key Product Segments and Market Indicators
  
  
  • Cardiovascular Drugs
    
  • Gastrointestinal Drugs
    
  • Infection Control Drugs
    
  • Neurotherapuetics and Central Nervous System Drugs
    
  • Oncology Drugs
    
  • Respiratory Drugs
    
  • Other Drugs
  
  
• Market Analysis
  
  
  • Product Segment Market Analysis
    
  • Competitor Outlook and Distribution

• Overview and Summary
  
• Regulatory Environment
  
• Economic Development
  
• Healthcare Trends in Russia
  
• Healthcare Professionals
  
• Demographics
  
  
  • Birth Rates
    
  • Life Expectancy
    
  • Mortality
    
  • Leading Causes of Death
  
  
• Key Product Segments and Market Indicators
  
  
  • Cardiovascular Drugs
    
  • Gastrointestinal Drugs
    
  • Infection Control Drugs
    
  • Neurotherapuetics and Central Nervous System Drugs
    
  • Oncology Drugs
    
  • Respiratory Drugs
    
  • Other Drugs
  
  
• Market Analysis
  
• Product Segment Market Analysis
  
• Competitive Outlook and Distribution

• Overview and Summary
  
• Regulatory Environment
  
• Economic Development
  
• Healthcare Trends in Brazil
  
• Healthcare Professionals
  
• Demographics
  
  
  • Birth Rates
    
  • Life Expectancy
    
  • Mortality
    
  • Leading Causes of Death
  
  
• Key Product Segments and Market Indicators
  
  
  • Cardiovascular Drugs
    
  • Gastrointestinal Drugs
    
  • Infection Control Drugs
    
  • Neurotherapuetics and Central Nervous System Drugs
    
  • Oncology Drugs
    
  • Respiratory Drugs
    
  • Other Drugs
  
  
• Market Analysis
  
• Product Segment Market Analysis
  
• Competitive Outlook and Distribution

• Overview
  
• Markets by Country

• Overview
  
• AstraZeneca
  
• GlaxoSmithKline
  
• Novartis AG
  
• Pfizer, Inc.
  
• Roche
  
• Sanofi-Aventis

CHAPTER ONE: EXECUTIVE SUMMARY

• Figure 1-1: BRIC Market Analysis: 2005-2012

CHAPTER TWO: INTRODUCTION

• Table 2-1: Percent of Smokers by Country, Adult Population 15+

  
  

• Table 2-2: Percent of Population that is Obese*, Estimated 2005

  
  

• Table 2-3: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006

  
  

• Figure 2-1: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006

  
  

• Table 2-4: Gross National Income Comparison by Country 2000-2005

  
  

• Figure 2-2: Gross National Income Growth by Country 2000-2005

CHAPTER THREE: PHARMACEUTICAL MARKETS IN INDIA

• Table 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Figure 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Table 3-2: India’s Economic Profile

  
  

• Table 3-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006

  
  

• Table 3-4: Healthcare Professionals in India by Type,
  Estimated 2004 and 2007

  
  

• Figure 3-2; Healthcare Professionals in India by Type, Estimated 2004 and 2007

  
  

• Table 3-5: India - Midyear Population, by Age and Sex, 2007 and 2012

  
  

• Figure 3-3: India - Midyear Population, by Age, 2007 and 2012

  
  

• Table 3-6: India Fertility Rates and Births Estimated
  2005, 2007; Projected 2008, 2025

  
  

• Figure 3-4: India Fertility Rates and Births, Estimated 2005, 2007; Projected 2008, 2025

  
  

• Table 3-7: India Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025

  
  

• Figure 3-5: India Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025

  
  

• Table 3-8: India Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Figure 3-6: India Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Table 3-9: India Leading Causes of Death, Estimated 2007

  
  

• Figure 3-7: India Leading Causes of Death, Estimated 2007

  
  

• Table 3-10: HIV Indicators, India

  
  

• Figure 3-8: HIV Indicators, India

  
  

• Table 3-11: Tuberculosis Surveillance and Epidemiology, India

  
  

• Figure 3-9: Tuberculosis Surveillance and Epidemiology, India

  
  

• Table 3-12: India Malaria Data, 1990-2003

  
  

• Figure 3-10: India Malaria Data, 1990-2003

  
  

• Table 3-13: Cancer Surveillance and Epidemiology, India

  
  

• Table 3-14: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World

  
  

• Figure 3-12: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World, 2007

  
  

• Table 3-15: India Pharmaceutical Market Analysis, 2005-2007

  
  

• Table 3-16: Forecasted India Pharmaceutical Market Analysis: 2008-2012

  
  

• Figure 3-13: India Pharmaceutical Market Analysis: 2005-2012

  
  

• Table 3-17: India Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012

  
  

• Figure 3-14: India Pharmaceutical Market Analysis by Product Segment, 2007

  
  

• Figure 3-15: India Pharmaceutical Market Forecast by Product Segment, 2012

  
  

• Table 3-18: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007

  
  

• Figure 3-16: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007

CHAPTER FOUR: PHARMACEUTICAL MARKETS IN CHINA

• Table 4-1: China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Figure 4-1: China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Table 4-2: Chinese and U.S. Drug Review Timeline

  
  

• Table 4-3: China’s Economic Profile

  
  

• Table 4-4: Gross National Income Per Capita and Growth Comparison for 2005 and 2006

  
  

• Table 4-5: Healthcare Professionals in China by Type, Estimated 2004 and 2007

  
  

• Figure 4-2: Healthcare Professionals in China by Type, Estimated 2004

  
  

• Table 4-6: China - Midyear Population, by Age and Sex, 2007 and 2012

  
  

• Figure 4-3: China - Midyear Population, by Age, 2007 and 2012

  
  

• Table 4-7: China Fertility Rates and Births
  (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Figure 4-4: China Fertility Rates and Births
  (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Table 4-8: China Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025

  
  

• Figure 4-5: China Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025

  
  

• Table 4-9: China Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Figure 4-6: China Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Table 4-10: China Leading Causes of Death, Estimated 2007

  
  

• Figure 4-7: China Leading Causes of Death, Estimated 2007

  
  

• Table 4-11: HIV Indicators, China

  
  

• Figure 4-8: HIV Indicators, China

  
  

• Table 4-12: Tuberculosis Surveillance and Epidemiology, China

  
  

• Figure 4-9: Tuberculosis Surveillance and Epidemiology, China

  
  

• Table 4-13: China Malaria Data, 1990-2003

  
  

• Figure 4-10: China Malaria Data, 1990-2003

  
  

• Table 4-14: Cancer Surveillance and Epidemiology, China

  
  

• Table 4-15: Estimated Cancer Incidence in China by Most Common Types of Cancer, Compared to World, 2007

  
  

• Figure 4-11: Estimated Cancer Incidence in China by Most Common Types of Cancer, Compared to World, 2007

  
  

• Table 4-16: China Pharmaceutical Market Analysis, 2005-2007

  
  

• Table 4-17: Forecasted China Pharmaceutical Market Analysis: 2008-2012

  
  

• Figure 4-12: China Pharmaceutical Market Analysis: 2005-2012

  
  

• Table 4-18: China Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012

  
  

• Figure 4-13: China Pharmaceutical Market Analysis
  by Product Segment, 2007

  
  

• Figure 4-14: China Pharmaceutical Market Forecast
  by Product Segment, 2012

  
  

• Table 4-19: Estimated Sales of Pharmaceuticals in China by Local and Foreign Suppliers, 2007

  
  

• Figure 4-15: Estimated Sales of Pharmaceuticals in China by Local and Foreign Suppliers, 2007

CHAPTER FIVE: PHARMACEUTICAL MARKETS IN RUSSIA

• Table 5-1: Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Figure 5-1: Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Table 5-2: Russia’s Economic Profile

  
  

• Table 5-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006

  
  

• Table 5-4: Healthcare Professionals in Russia by Type, Estimated 2004 and 2007

  
  

• Figure 5-2: Healthcare Professionals in Russia by Type, Estimated 2004 and 2007

  
  

• Table 5-5: Russia - Midyear Population, by Age and Sex, 2007 and 2012

  
  

• Figure 5-3: Russia - Midyear Population, by Age 2007 and 2012

  
  

• Table 5-6: Russia Fertility Rates and Births
  (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Figure 5-4: Russia Fertility Rates and Births (Estimated 2005, 2007; Projected 2008- 2025)

  
  

• Table 5-7: Russia Life Expectancy at Birth, 2005, 2006, 2007; (Projections, 2008 through 2012, and 2025)

  
  

• Figure 5-5: Russia Life Expectancy at Birth by Sex, 2005; Projections 2010 and 2025

  
  

• Table 5-8: Russia Mortality Rates and Numbers
  (Estimated 2005, 2007; Projected 2008, 2025)

  
  

• Figure 5-6: Russia Mortality Rates and Numbers Estimated 2005, 2007; Projected 2008, 2025

  
  

• Table 5-9: Russia Leading Causes of Death, Estimated 2007

  
  

• Figure 5-7: Russia Leading Causes of Death, Estimated 2007

  
  

• Table 5-10: HIV Indicators, Russia

  
  

• Figure 5-8: HIV Indicators, Russia

  
  

• Table 5-11: Tuberculosis Surveillance and Epidemiology, Russia

  
  

• Figure 5-9: Tuberculosis Surveillance and Epidemiology, Russia

  
  

• Table 5-12: Cancer Surveillance and Epidemiology, Russia

  
  

• Table 5-13: Estimated Cancer Incidence in Russia by Most Common Types of Cancer, Compared to World, 2007

  
  

• Figure 5-10: Estimated Cancer Incidence in Russia by Most Common Types of Cancer, Compared to World, 2007

  
  

• Table 5-14: Russia Pharmaceutical Market Analysis, 2005-2007

  
  

• Table 5-15: Forecasted Russia Pharmaceutical Market Analysis: 2008-2012

  
  

• Figure 5-11: Russia Pharmaceutical Market Analysis: 2005-2012

  
  

• Table 5-16: Russia Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012

  
  

• Figure 5-12: Russia Pharmaceutical Market Analysis by Product Segment, 2007

  
  

• Figure 5-13: Russia Pharmaceutical Market Forecast by Product Segment, 2012

  
  

• Table 5-17: Estimated Sales of Pharmaceuticals in Russia by Local and Foreign Suppliers, 2007

  
  

• Figure 5-14: Estimated Sales of Pharmaceuticals in Russia by Local and Foreign Suppliers, 2007

CHAPTER SIX: PHARMACEUTICAL MARKETS IN BRAZIL

• Table 6-1: Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Figure 6-1: Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012

  
  

• Table 6-2: Brazil’s Economic Profile

  
  

• Table 6-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006

  
  

• Table 6-4: Healthcare Professionals in Brazil by Type, Estimated 2004 and 2007

  
  

• Figure 6-2: Healthcare Professionals in Brazil by Type, Estimated 2004 and 2007

  
  

• Table 6-5: Brazil - Midyear Population, by Age and Sex, 2007 and 2012

  
  

• Figure 5-3: Brazil - Midyear Population, by Age and Sex, 2007 and 2012

  
  

• Table 6-6: Brazil Fertility Rates and Births

  
  

• Figure 6-4: Brazil Fertility Rates and Births

  
  

• Table 6-7: Brazil Life Expectancy at Birth, 2000, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025

  
  

• Figure 6-5: Brazil Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2025

  
  

• Table 6-8: Brazil Mortality Rates and Numbers

  
  

• Figure 6-6: Brazil Mortality Rates and Numbers

  
  

• Table 6-9: Brazil Leading Causes of Death, Estimated 2007

  
  

• Figure 6-7: Brazil Leading Causes of Death, Estimated 2007

  
  

• Table 6-10: Tuberculosis Surveillance and Epidemiology, Brazil

  
  

• Figure 6-8: Tuberculosis Surveillance and Epidemiology, Brazil

  
  

• Table 6-11: HIV Indicators, Brazil

  
  

• Figure 6-9: HIV Indicators, Brazil

  
  

• Table 6-12: Brazil Malaria Data, 1990-2003

  
  

• Figure 6-10: Brazil Malaria Data, 1990-2003

  
  

• Table 6-13: Cancer Surveillance and Epidemiology, Brazil

  
  

• Table 6-14: Estimated Cancer Incidence in Brazil by Most Common Types of Cancer, Compared to World

  
  

• Figure 6-11: Estimated Cancer Incidence in Brazil by Most Common Types of Cancer, Compared to World, 2007

  
  

• Table 6-15: Brazil Pharmaceutical Market Analysis, 2005-2007

  
  

• Table 6-16: Forecasted Brazil Pharmaceutical Market
  Analysis: 2008-2012

  
  

• Figure 6-12: Brazil Pharmaceutical Market Analysis: 2005-2012

  
  

• Table 6-17: Brazil Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012

  
  

• Figure 6-13: Brazil Pharmaceutical Market Analysis by Product Segment, 2007

  
  

• Figure 6-14: Brazil Pharmaceutical Market Forecast by
  Product Segment, 2012

  
  

• Table 6-18: Estimated Sales of Pharmaceuticals in Brazil by Local and Foreign Suppliers, 2007

  
  

• Figure 6-15: Estimated Sales of Pharmaceuticals in Brazil by Local and Foreign Suppliers, 2007

CHAPTER SEVEN: MARKET SUMMARY

• Table 7-1: BRIC Market Analysis, 2005-2007

  
  

• Table 7-2: Forecasted BRIC Market Analysis: 2008-2012

  
  

• Figure 7-1: BRIC Market Analysis: 2005-2012

  
  

• Table 7-3: World Pharmaceutical Markets by Country/Region, 2007

  
  

• Figure 7-2: World Pharmaceutical Markets by Country/Region, 2007

Abstract

Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market.

Kalorama's Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a solid look at opportunities available for pharmaceutical companies in these emerging markets, including the following information:

• Competitive Activity
• Current Market Size
• Forecast to 2012
• Population, Economy and Demographics
• Health Indicators for each Country
• Market Trends
• Company Profiles

• Cardiovascular Drugs
• Gastrointestinal Drugs
• Infection control Drugs
• Neurotherapeutics/CNS Drugs
• Oncology Drugs
• Respiratory Drugs
• Others

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel.

These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.